Henry Schein Inc (HSIC) Valuation
Historical valuation analysis based on 1279 data points (2021-09-14 to 2026-10-16)
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative...
Henry Schein Inc (HSIC) currently trades at a P/E ratio of 23.89 (historical range: 14.26–33.33, median: 21.96), placing it at the 76th percentile — above its historical average, P/S ratio of 0.71 (range: 0.59–1.03, 25th percentile — below its historical average), EV/EBITDA of 18.37 (range: 11.45–25.39, 66th percentile).
Over the historical period (2021-09-14 to 2026-10-16), Henry Schein Inc's P/E ratio has expanded by 28% over the observed period (from an average of 19.1 to 24.4).
Henry Schein Inc trades above its historical valuation range, with most metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/E Ratio | 23.89 | 21.96 | 76th | above its historical average |
| P/S Ratio | 0.71 | 0.76 | 25th | below its historical average |
| EV/EBITDA | 18.37 | 17.79 | 66th | above its historical average |
| FCF Yield | 5.91% | 5.44% | 64th | below its historical average |
Henry Schein Inc (HSIC) Valuation & P/E History
Henry Schein Inc (HSIC) is a US-listed stock operating in the Industrials sector, specifically the Wholesale-Medical, Dental & Hospital Equipment & Supplies industry currently trading at $85.82 with a market capitalization of $9.6 billion. This page provides historical valuation analysis for HSIC based on 1279 data points covering 2021-09-14 to 2026-10-16. The P/E ratio of 23.89 is above the historical median of 21.96, placing HSIC at the 76th percentile of its valuation range. The P/S ratio of 0.71 compares to a median of 0.76.
HSIC Valuation Metrics & Historical Range
The valuation table above shows Henry Schein Inc's current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether HSIC is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests HSIC is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for Henry Schein Inc.
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is HSIC Overvalued or Undervalued?
Henry Schein Inc trades above its historical valuation range, with most metrics above their median levels. The overall valuation percentile of 56 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive HSIC is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full HSIC analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.HSIC trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.

